Does Pennsylvania Medicaid Cover Wegovy or Zepbound?
Pennsylvania (PA) GLP-1 access depends on three state-specific policy questions before it ever gets to pricing: does Pennsylvania Medicaid cover weight-loss GLP-1s, has Pennsylvania expanded Medicaid under the ACA, and does the state employee health plan cover them. Answering those first tells you whether you're likely working with insurance or planning for cash-pay.
Pennsylvania Medicaid GLP-1 coverage: what the state's own documents say
Pennsylvania Medicaid stopped covering GLP-1 drugs for overweight and obesity for dates of service on or after January 1, 2026, in both fee-for-service and managed care; GLP-1s remain covered with prior authorization for other indications, and non-GLP-1 weight-loss drugs such as phentermine remain covered.
Checked September 20, 2026 against: pa.gov, pacodeandbulletin.gov, pa.gov.
Pennsylvania state employee health plan: what the plan's own documents say
Not verified. No current plan document for the Pennsylvania Employees Benefit Trust Fund could be read (its website serves a browser check to automated readers), so coverage of weight-loss GLP-1s in the Commonwealth employee plan is unconfirmed either way.
Notable insurers active in Pennsylvania (not independently verified): Highmark Blue Cross Blue Shield, Independence Blue Cross, UPMC Health Plan.
Why GLP-1 coverage varies this much by state
Medicaid is a state-federal partnership, not a single national program. Each state Medicaid agency sets its own preferred drug list (PDL) and prior-authorization criteria within federal minimum requirements. Weight-loss drugs are not a federally mandated Medicaid benefit, so states choose independently whether to cover them - which is why only 10 of 50 states currently do (Pennsylvania is not one of them).
State employee health plans are a useful bellwether. These plans cover hundreds of thousands of state workers and negotiate directly with pharmacy benefit managers, so their coverage decisions often signal where commercial insurers in that state are heading. North Carolina's State Health Plan, for example, ended coverage of weight-loss GLP-1s on April 1, 2024, after its board voted 4-3 to cut it citing the drugs' high cost - a case that other states and large employers have watched closely.
Medicaid expansion status shapes who even has coverage to begin with. States that haven't adopted ACA Medicaid expansion have narrower Medicaid eligibility overall, which - combined with the weight-loss GLP-1 exclusion most states apply regardless of expansion status - pushes a larger share of residents in those states toward commercial insurance, telehealth, or manufacturer self-pay as their only realistic path.
National reference pricing (same nationwide - your actual cost depends on your plan)
These prices are the same across all 50 states because manufacturer list prices, self-pay programs, and telehealth pricing don't vary by state - only insurance coverage and copay do, which is why the Pennsylvania-specific policy facts above matter more than the table below for predicting your actual cost.
| Drug | Covered by insurance | Manufacturer self-pay | Telehealth | Cash retail |
|---|---|---|---|---|
| Wegovy 14.9% weight loss | $63 | $349 | $329 | $1,349 |
| Ozempic 11.6% weight loss | $63 | - | $399 | $1,028 |
| Wegovy (oral 25mg) 13.6% weight loss | $63 | $149 | $449 | $1,349 |
| Zepbound 22.5% weight loss | $88 | $299 | $499 | $1,059 |
| Mounjaro 20.9% weight loss | $88 | - | $499 | $1,069 |
| Saxenda 8.4% weight loss | $63 | - | $399 | $1,349 |
| Foundayo (orforglipron) 14.7% weight loss | $63 | $149 | - | $1,099 |
| CagriSema 20.4% weight loss | $88 | $599 | - | $1,499 |
Cheapest cash-pay GLP-1 paths for Pennsylvania residents
Manufacturer direct prices (LillyDirect, NovoCare) are usually cheapest. Updated May 2026.
| Drug | Insurance | Mfr direct | Telehealth (brand) | Telehealth (compd) | Cash retail | Get it |
|---|---|---|---|---|---|---|
| Wegovy 14.9% weight loss | $63 | $349 | $329 | $249 cheapest | $1,349 | Get →ad |
| Ozempic 11.6% weight loss | $63 | - | $399 | $199 cheapest | $1,028 | Get →ad |
| Wegovy (oral 25mg) 13.6% weight loss | $63 | $149 cheapest | $449 | - | $1,349 | Get →ad |
| Zepbound 22.5% weight loss | $88 | $299 cheapest | $499 | $299 cheapest | $1,059 | Get →ad |
| Mounjaro 20.9% weight loss | $88 | - | $499 | $299 cheapest | $1,069 | Get →ad |
| Saxenda 8.4% weight loss | $63 | - | $399 cheapest | - | $1,349 | Get →ad |
| Foundayo (orforglipron) 14.7% weight loss | $63 | $149 cheapest | - | - | $1,099 | Get →ad |
Frequently asked questions
Does Pennsylvania Medicaid cover Wegovy or Zepbound for weight loss?
No - coverage ended January 1, 2026. Pennsylvania Medicaid stopped covering GLP-1 drugs for overweight and obesity for dates of service on or after January 1, 2026, in both fee-for-service and managed care; GLP-1s remain covered with prior authorization for other indications, and non-GLP-1 weight-loss drugs such as phentermine remain covered. This was checked against Pennsylvania's own documents on September 20, 2026; coverage rules change often, so confirm with your plan before relying on it. Coverage for type 2 diabetes (Ozempic, Mounjaro) is a separate question. Medicare's GLP-1 Bridge, which started July 1, 2026, works separately from Medicaid and applies in every state.
Has Pennsylvania expanded Medicaid under the ACA?
Yes - Pennsylvania has adopted Medicaid expansion, which broadens who qualifies for Medicaid coverage generally, though it does not by itself guarantee GLP-1 weight-loss coverage (see above).
Does the Pennsylvania state employee health plan cover Wegovy or Zepbound?
We could not verify this. Not verified. No current plan document for the Pennsylvania Employees Benefit Trust Fund could be read (its website serves a browser check to automated readers), so coverage of weight-loss GLP-1s in the Commonwealth employee plan is unconfirmed either way. Check the current plan documents or ask the plan directly.